OraCoat XyliMelts are oral-adhering discs developed to provide long-lasting relief from dry mouth (xerostomia), particularly during sleep. Unlike conventional lozenges or oral sprays, XyliMelts attach to the teeth or gums and gradually dissolve, releasing xylitol and moisturizing ingredients over several hours.

XyliMelts have been evaluated in clinical studies involving people with nighttime dry mouth, reduced saliva production, Sjögren’s disease and xerostomia following cancer treatment. This article examines how the discs work, how long they last and what published research reveals about their effectiveness.

How Do XyliMelts Work?

XyliMelts use specially designed oral-adhering disc technology. Each disc attaches to a suitable surface inside the mouth and gradually releases its ingredients as it dissolves. The formulation contains xylitol, a sugar-free sweetener, together with moisturizing and lubricating ingredients that help relieve oral dryness.

Unlike sprays and rinses that may provide only temporary relief, XyliMelts are designed to remain in place for several hours. Their slow-release technology is particularly useful during sleep, when saliva production naturally decreases and symptoms of dry mouth can become more noticeable.

Xylitol can help stimulate saliva production when the salivary glands remain functional. However, the moisturizing effect of the discs may also provide relief for people with significantly reduced saliva production, even when measurable saliva flow does not increase.

How Long Do XyliMelts Last in the Mouth?

According to the manufacturer and observations reported in clinical research, XyliMelts typically dissolve over different periods depending on whether they are used during the day or at night:

  • During the day: approximately 1–4 hours.
  • During sleep: approximately 4–8 hours.

During the day, speaking, eating, drinking, swallowing and increased saliva flow can accelerate dissolution. At night, the mouth is less active and saliva production is lower, allowing the discs to dissolve more slowly.

Individual results vary depending on saliva production, oral activity and disc placement. Clinical observations have reported that some users continued to experience the flavor or moisturizing effects of the discs approximately six hours after application during sleep.

It is important to distinguish between the time a disc takes to dissolve and the duration of symptom relief. The reported time ranges are not a guarantee that every individual will experience continuous relief for the same period.

What Do Clinical Studies Say About XyliMelts?

Several clinical studies and scientific reports have examined the effectiveness of XyliMelts and related oral-adhering disc technology. Research has explored perceived oral moisture, nighttime comfort, sleep quality, saliva production and potential effects on oral health.

2026 Clinical Trial: Dry Mouth After Head and Neck Radiotherapy

A randomized crossover trial published in Clinical Oral Investigations in February 2026 evaluated XyliMelts in 33 patients experiencing persistent dry mouth following radiotherapy for head and neck cancer.

The researchers compared xylitol-containing oral-adhering discs with water and assessed both subjective symptom relief and objectively measured saliva production.

The results showed:

  • Greater subjective symptom relief: 76% with adhesive discs compared with 24% with water.
  • Improved sleep continuity: 67% compared with 9%.
  • Willingness to continue treatment: 70% compared with 30%.
  • Saliva production: No significant changes were observed in measured salivary flow.

Participants also reported better perceived oral moisture and comfort when using the discs. The findings suggest that XyliMelts may provide meaningful symptomatic relief even when radiation-related salivary gland damage limits natural saliva production.

Although the results are encouraging, this was a relatively small study. Larger clinical trials are needed to confirm long-term effectiveness and safety across broader patient populations.

Study: Schoppmeier CM et al. (2026). Efficacy of adhesive discs for nocturnal xerostomia after head and neck radiotherapy: a randomized crossover trial. Clinical Oral Investigations, 30, 101.
View clinical study on PubMed

2012 Study: XyliMelts for Nighttime Oral Dryness

A study by Burgess and Lee, published in the International Journal of Dental Hygiene in 2012, investigated the use of slowly dissolving oral-adhering discs for nighttime xerostomia.

The researchers examined whether the discs could improve perceived oral moisture and reduce discomfort associated with dry mouth during sleep.

The study reported improvements in perceived oral wetness upon awakening and reduced discomfort among participants using XyliMelts. These findings provided early clinical evidence supporting oral-adhering discs as an option for managing nighttime dryness.

While the study supports the effectiveness of the technology for symptom management, its findings should be considered alongside more recent research.

Study: Burgess J, Lee P. (2012). XyliMelts time-release adhering discs for night-time oral dryness. International Journal of Dental Hygiene, 10(2), 118–121.
View clinical study on PubMed

Research in Patients with Sjögren’s Disease

Sjögren’s disease is an autoimmune condition that commonly affects the salivary and tear glands, leading to persistent dryness of the mouth and eyes.

A study published in Clinical Oral Investigations examined dry mouth interventions among 92 patients with Sjögren’s disease. The researchers assessed patient experiences with different remedies, including chewing gum, moisturizing gels, prescription medications, water and XyliMelts.

Among the interventions receiving favorable patient-reported assessments were chewing gum, mouth gels and XyliMelts.

The findings suggest that oral-adhering discs may be a useful option for some people with Sjögren’s disease. However, patient-reported effectiveness does not establish that one treatment is universally superior to another.

Study: Assy Z et al. (2023). Use and efficacy of dry-mouth interventions in Sjögren’s disease patients and possible association with perceived oral dryness and patients’ discomfort. Clinical Oral Investigations.
View published research

Research in Patients with Reduced Saliva Production

Additional research has investigated oral-adhering discs in people with hyposalivation, a condition characterized by objectively reduced saliva production.

A 2017 study by Ho and colleagues explored the effects of a novel disc formulation on symptoms of dry mouth and enamel remineralization in patients with hyposalivation.

Participants reported improvements in perceived mouth wetness upon awakening, and some reported that the effects and flavor of the discs lasted approximately six hours during sleep.

The study also investigated potential effects on enamel remineralization. While these findings are of scientific interest, further independent research is needed before drawing broad conclusions about long-term prevention of dental decay.

Study: Ho J et al. (2017). Effects of a Novel Disc Formulation on Dry Mouth Symptoms and Enamel Remineralization in Patients With Hyposalivation: An In Vivo Study. Dentistry, 7, 411.
View study details

Other Clinical Research and Observations

Additional research and clinical reports have explored XyliMelts in hospice patients, people with persistent xerostomia and individuals experiencing oral health complications associated with reduced saliva production.

A small report involving 18 hospice patients described favorable symptom relief and tolerability after using XyliMelts when previously used moisturizing products had provided insufficient relief.

Individual case reports have also described improvements in dental and gingival conditions during XyliMelts use. However, case reports cannot establish a direct cause-and-effect relationship or prove that the product prevents tooth decay.

Research has additionally examined oral acidity, enamel effects and possible relationships between nighttime oral moisture and acid reflux symptoms. These findings should be interpreted cautiously because the available studies differ in quality, design and sample size.

Why Is Xylitol Important for Oral Health?

Xylitol is a sugar alcohol commonly used as a sugar substitute in dental and oral-care products. Unlike ordinary sugar, it is not readily fermented by common oral bacteria into acids that contribute to tooth enamel demineralization.

Xylitol-containing products can also encourage saliva flow through taste stimulation and oral activity. This can be particularly helpful for people whose salivary glands retain some function.

Each standard XyliMelts disc contains approximately 550 mg of xylitol, according to the manufacturer. The gradual release is intended to support oral moisture over an extended period.

Although xylitol has properties that make it useful in oral care, the strength of evidence for preventing cavities varies across products and studies. XyliMelts should therefore be considered a supplement to, rather than a replacement for, established preventive dental measures such as fluoride toothpaste and regular dental examinations.

Information for Dental and Healthcare Professionals

Xerostomia can affect quality of life, sleep, oral health, nutritional intake and the ability to speak or swallow comfortably. It is commonly associated with medication use, Sjögren’s disease, head and neck radiotherapy, systemic health conditions and mouth breathing during sleep.

For healthcare professionals, an important distinction is the difference between xerostomia, the subjective sensation of oral dryness, and hyposalivation, an objectively measured reduction in salivary flow.

These conditions often occur together but are not identical. A treatment may improve perceived moisture and comfort without significantly increasing measured saliva production. The 2026 radiotherapy trial provides an example of this distinction.

OraCoat XyliMelts may be considered as one component of symptom-oriented dry mouth management. The oral-adhering technology is designed for gradual ingredient release, including during sleep, when conventional rinses or sprays may be less practical.

Clinical management should also include assessment of underlying causes, medication reviews where appropriate, preventive dental care and suitable treatment of associated medical conditions. Product suitability should be assessed individually, particularly in patients with swallowing difficulties or complex medical needs.

What Can Be Concluded from the Research?

Published clinical research provides encouraging evidence that XyliMelts can improve perceived oral moisture and reduce discomfort for some people experiencing dry mouth, particularly during sleep.

The 2026 randomized crossover study demonstrated improvements in subjective symptom relief and sleep continuity among patients with radiotherapy-induced xerostomia, even though measured saliva production did not increase. Earlier studies and patient-reported research provide additional support for the potential benefits of oral-adhering discs.

Nevertheless, the available evidence has limitations. Several studies involve relatively small patient groups, some findings rely on subjective assessments, and additional research is needed to determine long-term outcomes across different causes of dry mouth.

OraCoat XyliMelts offer a research-supported option for managing dry mouth symptoms, particularly for people seeking longer-lasting nighttime comfort. They do not cure xerostomia or treat the underlying medical conditions responsible for reduced saliva production, but they may form a useful part of a comprehensive oral-care routine.

Clinical Studies and Scientific References